Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 245 Records) |
| Query Trace: Neoplasms and ARID1A[original query] |
|---|
| High Expression of FOXO3 in Gastric Cancer Tissues is Associated with Poor Prognosis and Immune Cell Infiltration. Clinical laboratory 2023 9 69 (9): . Bingzheng Zhong, Ziwei Yin, Xiaofeng Guo, Xiao Zhang, Xi Dou, Qiang Wa |
| Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
| Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer. Cancer genetics 2023 8 278-279 9-16. Tine Henrichsen Schnack, Douglas-V N P Oliveira, Anne Pernille Christiansen, Claus Høgdall, Estrid Høgda |
| Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3. Journal of cellular and molecular medicine 2023 8 . Jianxiong Li, Zexin Chen, Wentao Xiao, Huaguo Liang, Yanan Liu, Wenqi Hao, Yongli Zhang, Fengxiang W |
| Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience. Journal of gynecologic oncology 2023 7 . Yoo-Na Kim, Yun Soo Chung, Ji Hyun Lee, Eunhyang Park, Seung-Tae Lee, Sunghoon Kim, Jung-Yun L |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. Biomarker research 2023 7 11 (1): 68. Ya-Sian Chang, Siang-Jyun Tu, Hong-Da Chen, Chin-Chun Chung, Ming-Hon Hsu, Yu-Pao Chou, Ya-Ting Lee, Ju-Chen Yen, Long-Bin Jeng, Jan-Gowth Cha |
| The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma. The journal of pathology. Clinical research 2023 7 . Bo Sun, Haojie Chen, Jiawen Lao, Cong Tan, Yue Zhang, Zhen Shao, Dazhi |
| Racial and sex differences in tumor genomics in urothelial carcinoma. Urologic oncology 2023 7 . Yaw A Nyame, Kelsey K Baker, Bruce Montgomery, Petros Grivas, Mary W Redman, Jonathan L Wrig |
| Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling. Cancers 2023 7 15 (13): . Yinan Wang, Hui Du, Wenkui Dai, Cuijun Bao, Xi Zhang, Yan Hu, Zhiyu Xie, Xin Zhao, Changzhong Li, Wenyong Zhang, Ruifang |
| Unique Genomic Alterations and Microbial Profiles Identified in Gastric Cancer Patients of African, European, and Asian Ancestry: A Novel Path for Precision Oncology. Annals of surgery 2023 7 . Miseker Abate, Henry Walch, Kanika Arora, Chad M Vanderbilt, Teng Fei, Harrison Drebin, Shoji Shimada, Anna Maio, Yelena Kemel, Zsofia K Stadler, Joseph Schmeltz, Smita Sihag, Geoffrey Y Ku, Ping Gu, Laura Tang, Santosha Vardhana, Michael F Berger, Murray F Brennan, Nikolaus D Schultz, Vivian E Stro |
| Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
| CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database. Japanese journal of clinical oncology 2023 6 . Kenya Kobayashi, Yuki Saito, Hidenori Kage, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamaso |
| The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Gynecologic oncology 2023 6 175 133-141. Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua |
| Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial. Cancer medicine 2023 6 . Qingjiang Hu, Eiji Oki, Teppei Yamada, Tomomi Kashiwada, Hideto Sonoda, Masato Kataoka, Hirofumi Kawanaka, Yasushi Tsuji, Akitaka Makiyama, Yuichiro Nakashima, Mitsuhiko Ota, Yasue Kimura, Tomoharu Yoshizu |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| The mutation and low expression of ARID1A are predictive of a poor prognosis and high immune infiltration in triple-negative breast cancer. Current cancer drug targets 2023 5 . Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang, Jie |
| Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications. Trends in molecular medicine 2023 5 . Fukang Jin, Zhiguang Yang, Jingbo Shao, Jianxin Tao, Christoph Reißfelder, Sonja Loges, Lei Zhu, Sebastian Schöl |
| Comprehensive Genome profile testing in head and neck cancer. Auris, nasus, larynx 2023 5 . Masashi Kuroki, Ryota Iinuma, Hiroshi Okuda, Kosuke Terazawa, Hirofumi Shibata, Ken-Ichi Mori, Toshimitsu Ohashi, Akitaka Makiyama, Manabu Futamura, Tatsuhiko Miyazaki, Yukio Horikawa, Takenori Oga |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 3 JCO2202144. Sarfaty Michal, Golkaram Mahdi, Funt Samuel A, Al-Ahmadie Hikmat, Kaplan Shannon, Song Fan, Regazzi Ashley, Makarov Vladimir, Kuo Fengshen, Ostrovnaya Irina, Seshan Venkatraman, Zhao Chen, Greenbaum Benjamin, Liu Li, Rosenberg Jonathan E, Chan Timothy |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology 2023 3 14 1090838. Li Mengyuan, Gao Xuejiao, Wang Xiaoshe |
| Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 36 (5): 100123. Irshaid Lina, Costigan Danielle C, Dong Fei, Matulonis Ursula A, Nucci Marisa R, Kolin David |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma. Gene 2023 2 860 147233. Altun Zekiye, Yuan Hongling, Baran Burçin, Akta? Safiye, Sönmez Esra Esmeray, Küçük Can, Olgun N |
| ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2023 2 . Sato Takahiro, Saito Motonobu, Nakajima Shotaro, Saito Katsuharu, Katagata Masanori, Fukai Satoshi, Okayama Hirokazu, Sakamoto Wataru, Saze Zenichiro, Momma Tomoyuki, Mimura Kosaku, Kono Ko |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer. British journal of cancer 2023 2 . Asami Yuka, Kobayashi Kato Mayumi, Hiranuma Kengo, Matsuda Maiko, Shimada Yoko, Ishikawa Mitsuya, Koyama Takafumi, Komatsu Masaaki, Hamamoto Ryuji, Nagashima Minoru, Terao Yasuhisa, Itakura Atsuo, Kohno Takashi, Sekizawa Akihiko, Matsumoto Koji, Kato Tomoyasu, Shiraishi Kouya, Yoshida Hiros |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: